News

Video

Ovarian Cancer Survivor Reflects on Doctor’s Support That Eased Surgery Fears

Author(s):

Fact checked by:

Barbera credits Dr. Donna Klobocista’s compassionate guidance before surgery for giving her confidence; now she mentors others facing ovarian cancer.

When Mary Barbera was diagnosed with stage 3C ovarian cancer at age 48, she found strength in the guidance of her dedicated care team at John Theurer Cancer Center. Ahead of her surgery, Dr. Donna Klobocista took time to walk through every step of the process, explaining what to expect and even drawing diagrams to help Mary and her husband fully understand what might happen and why.

This thorough and compassionate approach gave Mary confidence going into surgery and helped ease her fears during an incredibly vulnerable time. Although her journey also included the later loss of her husband, she felt fully prepared for what was ahead thanks to the groundwork her team had laid. She also credits nurse Aretha DiSalvo and Dr. Sarah McNamara for their vital roles in her treatment and recovery. Now at age 56 and in remission, she mentors others facing cancer, offering the same reassurance, strength and perspective she once received — and reminding them they are never alone.

Transcript:

How did Klobocista’s approach help ease your fears before surgery?

Well, I lost my husband while I was sick, but at the time I was diagnosed, he was still with us. We had a meeting with Klobocista before my surgery. We went to the cancer center and sat in her office, and she really took her time with us. She went through everything — step by step — and explained exactly what would happen and what might happen. She even drew pictures to help us visualize it all.

She was incredibly thorough and honest, and everything she said would happen, did happen. Even the things she said might happen — unfortunately, they did. But because of her, I was fully prepared. I knew what to expect, and that helped so much. She just made me feel ready. I had confidence in her.

Transcript has been edited for clarity and conciseness

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
Image of Dr. Zhaoming Wang with text.
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Woman with text.
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Related Content